Lv1
60 积分 2024-01-17 加入
Structural basis for LZTR1 recognition of RAS GTPases for degradation
3个月前
已完结
Mechanisms of genomic resistance across emerging classes of KRAS inhibitors
4个月前
已完结
Focused Structure-Based Virtual Screening Identifies Novel Inhibitors of SOS1
4个月前
已完结
Solid-State Evaluation of a Newly Emerged Polymorph for Early-Stage Pharmaceutical Development
6个月前
已完结
9 Oral: BBO-10203, an orally bioavailable small molecule that disrupts the RAS-PI3Kα interaction leading to pAKT and tumor growth inhibition in models of breast, lung and colorectal cancer
7个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
7个月前
已完结
皖公网安备34019202002308
